FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204124777> ?p ?o ?g. }

• W3204124777 abstract "Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), explore reasons for switching and to compare results to previously published data. Methods: Time-to-event analysis for mean treatment duration (estimated as the Restricted Mean Survival Time), b/tsDMARD failure, and b/tsDMARDs switching was performed for 230 patients (n = 147 RA, 46 PsA, 37 AS) who commenced their first b/tsDMARD between 2008 and 2018. Patients were managed in a dedicated biologics clinic in a tertiary hospital; the choice of b/tsDMARD was clinician driven based on medical factors and patient preferences. The effect of covariates on switching risk was analysed by a conditional risk-set Cox proportional-hazards model. Treatment retention data was compared to a historical analysis (2002-2008). Results: The proportions remaining on treatment (retention) were similar, throughout follow-up, for the first, second and third b/tsDMARDs across all patients (p = 0.46). When compared to RA patients, the risk of b/tsDMARD failure was halved in PsA patients [Hazard Ratio (HR) = 0.50], but no different in AS patients (HR = 1.0). The respective restricted mean (95%CI) treatment durations, estimated at 5 years of follow-up, were 3.1 (2.9, 3.4), 4.1 (3.7, 4.6), and 3.3 (2.8, 3.9) years, for RA, PsA, and AS, respectively. Age, gender, disease duration, smoking status and the use of concomitant csDMARDS were not associated with the risk of bDMARD failure. The most common reasons for switching in the first and subsequent years were secondary (n = 62) and primary (n = 35) failure. Comparison with historical data indicated no substantive differences in switching of the first biologic for RA and PsA. Conclusion: Similar retention rates of the second and third compared to the first b/tsDMARD in RA, PsA, and AS support a strategy of differential b/tsDMARDs use informed by patient presentation. Despite greater availability of b/tsDMARDs with differing mechanisms of action, retention rates of the first b/tsDMARD remain similar to previous years." @default.
• W3204124777 created "2021-10-11" @default.
• W3204124777 creator A5004338684 @default.
• W3204124777 creator A5007660602 @default.
• W3204124777 creator A5007753899 @default.
• W3204124777 creator A5010578298 @default.
• W3204124777 creator A5026779492 @default.
• W3204124777 creator A5048438051 @default.
• W3204124777 creator A5056597116 @default.
• W3204124777 creator A5062317341 @default.
• W3204124777 creator A5066921526 @default.
• W3204124777 creator A5078271584 @default.
• W3204124777 creator A5083125389 @default.
• W3204124777 creator A5087398493 @default.
• W3204124777 date "2021-09-27" @default.
• W3204124777 modified "2023-10-16" @default.
• W3204124777 title "Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis" @default.
• W3204124777 cites W1161145218 @default.
• W3204124777 cites W1587015012 @default.
• W3204124777 cites W1654800013 @default.
• W3204124777 cites W1857270174 @default.
• W3204124777 cites W1867182292 @default.
• W3204124777 cites W1877953244 @default.
• W3204124777 cites W1966439074 @default.
• W3204124777 cites W1966756501 @default.
• W3204124777 cites W1969908269 @default.
• W3204124777 cites W1973918030 @default.
• W3204124777 cites W2007486550 @default.
• W3204124777 cites W2022194132 @default.
• W3204124777 cites W2035320881 @default.
• W3204124777 cites W2039321888 @default.
• W3204124777 cites W2043124279 @default.
• W3204124777 cites W2047529624 @default.
• W3204124777 cites W2060221163 @default.
• W3204124777 cites W2063671947 @default.
• W3204124777 cites W2082866542 @default.
• W3204124777 cites W2092666560 @default.
• W3204124777 cites W2101868943 @default.
• W3204124777 cites W2106207910 @default.
• W3204124777 cites W2106914983 @default.
• W3204124777 cites W2106962952 @default.
• W3204124777 cites W2116843833 @default.
• W3204124777 cites W2118378094 @default.
• W3204124777 cites W2119729506 @default.
• W3204124777 cites W2122820337 @default.
• W3204124777 cites W2131547492 @default.
• W3204124777 cites W2140641725 @default.
• W3204124777 cites W2140965629 @default.
• W3204124777 cites W2141036320 @default.
• W3204124777 cites W2142632855 @default.
• W3204124777 cites W2145159920 @default.
• W3204124777 cites W2145230025 @default.
• W3204124777 cites W2149447280 @default.
• W3204124777 cites W2152291919 @default.
• W3204124777 cites W2156148414 @default.
• W3204124777 cites W2166232525 @default.
• W3204124777 cites W2172742237 @default.
• W3204124777 cites W2242586181 @default.
• W3204124777 cites W2255303688 @default.
• W3204124777 cites W2285407069 @default.
• W3204124777 cites W2404262996 @default.
• W3204124777 cites W2514747484 @default.
• W3204124777 cites W2523119278 @default.
• W3204124777 cites W2549844032 @default.
• W3204124777 cites W2558871347 @default.
• W3204124777 cites W2593480788 @default.
• W3204124777 cites W2602199935 @default.
• W3204124777 cites W2622023924 @default.
• W3204124777 cites W2734111082 @default.
• W3204124777 cites W2742024730 @default.
• W3204124777 cites W2762730732 @default.
• W3204124777 cites W2765382572 @default.
• W3204124777 cites W2800436395 @default.
• W3204124777 cites W2891139352 @default.
• W3204124777 cites W2894751050 @default.
• W3204124777 cites W2917180277 @default.
• W3204124777 cites W2948813200 @default.
• W3204124777 cites W2995362802 @default.
• W3204124777 cites W3003812743 @default.
• W3204124777 cites W3017389231 @default.
• W3204124777 cites W3026155297 @default.
• W3204124777 cites W3070492395 @default.
• W3204124777 cites W3120248879 @default.
• W3204124777 cites W4231972505 @default.
• W3204124777 doi "https://doi.org/10.3389/fmed.2021.708168" @default.
• W3204124777 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8502861" @default.
• W3204124777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34646840" @default.
• W3204124777 hasPublicationYear "2021" @default.
• W3204124777 type Work @default.
• W3204124777 sameAs 3204124777 @default.
• W3204124777 citedByCount "4" @default.
• W3204124777 countsByYear W32041247772022 @default.
• W3204124777 countsByYear W32041247772023 @default.
• W3204124777 crossrefType "journal-article" @default.
• W3204124777 hasAuthorship W3204124777A5004338684 @default.
• W3204124777 hasAuthorship W3204124777A5007660602 @default.
• W3204124777 hasAuthorship W3204124777A5007753899 @default.
• W3204124777 hasAuthorship W3204124777A5010578298 @default.
• W3204124777 hasAuthorship W3204124777A5026779492 @default.
• W3204124777 hasAuthorship W3204124777A5048438051 @default.

• next